Over-expression of protein kinase C isoforms (α, δ, θ and ζ) in squamous cervical cancer

Neoplasma

Volumn 58, Issue 6, 2011, Pages 491-498

  Yu, L R ^a   Lv, J Q ^a   Jin, L Y ^a   Ding, S D ^a   Ma, X Y ^a   Wang, J J ^a   Zhu, X Q ^a  

^a THE SECOND AFFILIATED HOSPITAL AND YUYING CHILDREN S HOSPITAL OF WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Cervical cancer; Isoforms; Protein kinase C

Indexed keywords

PROTEIN KINASE C ALPHA; PROTEIN KINASE C DELTA; PROTEIN KINASE C THETA; PROTEIN KINASE C ZETA; PROTEIN KINASE C; PROTEIN KINASE C EPSILON;

ADULT; ARTICLE; CELL DIFFERENTIATION; CLINICAL ARTICLE; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PROTEIN EXPRESSION; SQUAMOUS CERVICAL CANCER; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; WESTERN BLOTTING; CASE CONTROL STUDY; COMPARATIVE STUDY; ENZYME IMMUNOASSAY; LYMPH NODE METASTASIS; METABOLISM; METASTASIS; MIDDLE AGED; PATHOLOGY; PROGNOSIS; SQUAMOUS CELL CARCINOMA; TUMOR RECURRENCE; UTERINE CERVIX; UTERINE CERVIX TUMOR;

ADULT; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; PROTEIN KINASE C; PROTEIN KINASE C-ALPHA; PROTEIN KINASE C-DELTA; PROTEIN KINASE C-EPSILON; UTERINE CERVICAL NEOPLASMS;

EID: 84857463679     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: 10.4149/neo_2011_06_491     Document Type: Article

References (29)

1. NISHIZUKA Y. Protein kinase C and lipid signaling for sustained cellular responses. FASEB J 1995; 9: 484-496.
2. NEWTON AC. Regulation of protein kinase C. Curr Opin Cell. Biol 1997; 9: 161-167. doi:10.1016/S0955-0674(97)80058-0
3. KOIVUNEN J, AALTONEN V, PELTONEN J. Protein kinase C (PKC) family in cancer progression. Cancer Lett 2005; 235: 1-10. doi:10.1016/j.canlet.2005.03.033
4. VARGA A, CZIFRA G, TALLAI B, NEMETH T, KOVACS I et al. Tumor grade-dependent alterations in the protein kinase C isoform pattern in urinary bladder carcinomas. Eur Urol 2004; 46: 462-465. doi:10.1016/j.eururo.2004.04.014
5. FOURNIER DB, CHISAMORE M, LURAIN JR, RADEMAKER AW, JORDAN VC et al. Protein kinase C alpha expression is inversely related to ER status in endometrial carcinoma: possible role in AP-1-mediated proliferation of ER-negative endometrial cancer. Gynecol Oncol 2001; 81: 366-372. doi:10.1006/gyno.2001.6164
6. WU TT, HSIEH YH, WU CC, HSIEH YS, HUANG CY et al. Over-expression of protein kinase C α mRNA in human hepato-cellular carcinoma: A potential marker of disease prognosis. Clin Chim Acta 2007; 382: 54-58. doi:10.1016/j.cca.2007.03.018
7. GOKMEN-POLAR Y, MURRAY NR, VELASCO MA, GATALICA Z, FIELDS AP. Elevated protein kinase C beta II is an early promotive event in colon carcinogenesis. Cancer Res 2001; 61: 1375-1381.
8. KIM KM, KANG DW, MOON WS, PARK JB, PARK CK et al. PKC theta expression in gastrointestinal stromal tumor. Mod. Pathol 2006; 19: 1480-1486. doi:10.1038/modpathol.3800673
9. BELGUISE K, SONENSHEIN GE. PKC θ promotes c-Rel-driven mammary tumorigenesis in mice and humans by repressing estrogen receptor α synthesis. J Clin Invest 2007; 117: 4009-4021. doi:10.1172/JCI32424
10. EVANS JD, CORNFORD PA, DODSON A, NEOPTOLEMOS JP, FOSTER CS. Expression patterns of protein kinase C isoenzymes are characteristically modulated in chronic pancreatitis and pancreatic cancer. Am J Clin Pathol 2003; 119: 392-402. doi:10.1309/BKPC9DX98R781B87
11. MCKIERNAN E, O'BRIEN K, GREBENCHTCHIKOV N, GEURTS-MOESPOT A, SIEUWERTS AM et al. Protein kinase C δ expression in breast cancer as measured by realtime PCR, western blotting and ELISA. Br J Cancer 2008; 99: 1644-1650. doi:10.1038/sj.bjc.6604728
12. PODAR K, RAAB MS, CHAUHAN D, ANDERSON KC. The therapeutic role of targeting protein kinase C in solid and hematologic malignancies. Expert Opin Investig Drugs 2007; 16: 1693-1707. doi:10.1517/13543784.16.10.1693
13. PAN Z, CHEN S, PAN X, WANG Z, HAN H et al. Differential gene expression identified in Uigur women cervical squamous. cell carcinoma by suppression subtractive hybridization. Neoplasma 2010; 57: 123-128. doi:10.4149/neo_2010_02_123
14. TJALMA WA, VAN WAES TR, VAN DEN EEDEN LE, BOQERS JJ. Role of human papillomavirus in the carcinogenesis of squamous cell carcinoma and adenocarcinoma of the cervix. Best Pract Res Clin Obstet Gynaecol 2005; 19: 469-483. doi:10.1016/j.bpobgyn.2005.02.002
15. ZHU X, LV J, YU L, ZHU X, WU J et al. Proteomic identification of differentially-expressed proteins in squamous cervical cancer. Gynecol Oncol 2009; 112: 248-256. doi:10.1016/ j.ygyno.2008.09.045
16. WANG M, XUE L, CAO Q, LIN Y, DING Y et al. Expression of Notch1, Jagged1 and beta-catenin and their clinicopathological significance in hepatocellular carcinoma. Neoplasma 2009; 56: 533-541. doi:10.4149/neo_2009_06_533
17. KOIVUNEN J, AALTONEN V, KOSKELA S, LEHENKARI P, LAATO M et al. Protein kinase C alpha/beta inhibitor Go6976 promotes formation of cell junctions and inhibits invasion of urinary bladder carcinoma cells. Cancer Res 2004; 64: 5693-5701. doi:10.1158/0008-5472.CAN-03-3511
18. JIANG XH, TU SP, CUI JT, LIN MC, XIA HH et al. Antisense targeting protein kinase C alpha and beta1 inhibits gastric carcinogenesis. Cancer Res. 2004; 64: 5787-5794. doi:10.1158/0008-5472.CAN-03-1172
19. LEIRDAL M, SIOUD M. Ribozyme inhibition of the protein kinase C alpha triggers apoptosis in glioma cells. Br J Cancer 1999; 80: 1558-1564. doi:10.1038/sj.bjc.6690560
20. CAMERON AJ, PROCYK KJ, LEITGES M, PARKER PJ. PKC alpha protein but not kinase activity is critical for glioma cell proliferation and survival. Int J Cancer 2008; 123: 769-779. doi:10.1002/ijc.23560
21. WU TT, HSIEH YH, HSIEH YS, LIU JY. Reduction of PKC alpha decreases cell prolifelation,migration,and invasion of human malignant hepatocellular carcinoma. J Cell Biochem 2008; 103: 9-20. doi:10.1002/jcb.21378
22. TOKUDA H, HOSOI T, HAYASAKA K, OKAMURA K, YOSHIMI N et al. Over expression of protein kinase C-delta plays a crucial role in interleukin-6-producing pheochromo-cytoma presenting with acute inflammatory syndrome: a case report. Horm Metab Res 2009; 41: 333-338. doi:10.1055/s-0028-1103300
23. MELLER N, ALTMAN A, ISAKOV N. New Perspectives on PKC θ, a Member of the Novel Subfamily of Protein Kinase C. Stem Cells 1998; 16: 178-192. doi:10.1002/stem.160178
24. MOSCAT J, RENNERT P, DIAZ-MECO MT. PKC zeta at the crossroad of NF-kappa B and Jak1/Stat6 signaling pathways. Cell Death Differ 2006; 13: 702-711. doi:10.1038/ sj.cdd.4401823
25. HIRA T, CHIDA K. Protein kinase C zeta (PKC zeta): activation mechanisms and cellular functions. J Bio. Chem 2003; 133: 1-7. doi:10.1093/jb/mvg017
26. PAL S, CLAFFEY KP, COHEN HT. Activation Sp l-mediated vascular permeability factor/vascular endothelial growth factor transcription requires specific interaction with protein kinase C zeta. J Biol. Chem 1998; 273: 26277-26280. doi:10.1074/jbc.273.41.26277
27. GUO H, MA Y, ZHANG B, SUN B, NIU R et al. Pivotal advance: PKC zeta is required for migration of macrophages. J Leukoc Biol. 2009; 85: 911-918. doi:10.1189/jlb.0708429
28. WU J, ZHANG B, WU M, LI H, NIU R et al. Screening of a PKC zeta-specific kinase inhibitor PKCzI257.3 which inhibits EGF-induced breast cancer cell chemotaxis. Invest New Drugs 2010; 28: 268-275. doi:10.1007/s10637-009-9242-8
29. SANZ-NAVARES E, FERNANDEZ N, KAZANIETZ MG, ROTENBERG SA. Atypical protein kinase C ζ suppresses migration of mouse melanoma cells. Cell Growth Differ 2001; 12: 517-524.